Drug Trial News

RSS
CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

31 Mar 2011
Boceprevir drug can help cure hard-to-treat hepatitis C

Boceprevir drug can help cure hard-to-treat hepatitis C

31 Mar 2011
Amgen appeals EMA CHMP negative opinion on Vectibix-chemotherapy combination for wild-type KRAS mCRC

Amgen appeals EMA CHMP negative opinion on Vectibix-chemotherapy combination for wild-type KRAS mCRC

31 Mar 2011
Three-drug cocktail more effective against hepatitis C virus

Three-drug cocktail more effective against hepatitis C virus

31 Mar 2011
Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

31 Mar 2011
MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

30 Mar 2011
Amgen announces top-line results from motesanib Phase 3 trial against NSCLC

Amgen announces top-line results from motesanib Phase 3 trial against NSCLC

30 Mar 2011
BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

30 Mar 2011
Pharmasset commences PSI-7977 Phase 2b study against HCV

Pharmasset commences PSI-7977 Phase 2b study against HCV

30 Mar 2011
Columbia Labs' PROCHIEVE Phase III trial results to be published in online medical journal

Columbia Labs' PROCHIEVE Phase III trial results to be published in online medical journal

30 Mar 2011
SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

30 Mar 2011
Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

30 Mar 2011
Positive results from Vertex VX-770 Phase 3 trial against CF

Positive results from Vertex VX-770 Phase 3 trial against CF

30 Mar 2011
Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

30 Mar 2011
Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

30 Mar 2011
New lung cancer drug starts human trials

New lung cancer drug starts human trials

29 Mar 2011
Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy

Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy

29 Mar 2011
Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

29 Mar 2011
Keryx KRX-0401 trial data against colorectal cancer, multiple myeloma to be presented at AACR

Keryx KRX-0401 trial data against colorectal cancer, multiple myeloma to be presented at AACR

29 Mar 2011
Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

29 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback